trimetazidine has been researched along with Diabetic Angiopathies in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaszner, B; Hild, G; Kónyi, A; Meiszterics, Z; Sárszegi, Z | 1 |
| Fi, Z; Kovács, G; Szentes, V | 1 |
| Gil Polo, B; Maicas Bellido, C; Rodríguez Padial, L; Velázquez Martín, M | 1 |
| Celik, T; Iyisoy, A; Jata, B; Kursaklioglu, H | 1 |
| Marazzi, G; Rosano, GM; Volterrani, M | 1 |
| Domzał-Bocheńska, M; Elikowski, W; Gajos, G; Kałuza, G; Kulon, I; Kuźniak, M; Pachocki, R; Paradowski, A; Sadowski, Z; Szwed, H; Szydłowski, Z; Szymczak, K; Wator-Brzezińska, A | 1 |
| Pogatsa, G | 1 |
2 review(s) available for trimetazidine and Diabetic Angiopathies
| Article | Year |
|---|---|
[Role of trimetazidine in the treatment of diabetic microangiopathy in ischaemic heart disease].
Topics: Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Heart; Humans; Myocardial Infarction; Myocardial Ischemia; Myocardium; Trimetazidine; Vasodilator Agents | 2015 |
Metabolic energy metabolism in diabetes: therapeutic implications.
Topics: Angina Pectoris; Animals; Circadian Rhythm; Diabetic Angiopathies; Energy Metabolism; Glycolysis; Humans; Myocardial Reperfusion; Myocardium; Trimetazidine; Vasodilator Agents | 2001 |
1 trial(s) available for trimetazidine and Diabetic Angiopathies
| Article | Year |
|---|---|
The antiischemic effects and tolerability of trimetazidine in coronary diabetic patients. A substudy from TRIMPOL-1.
Topics: Diabetes Complications; Diabetic Angiopathies; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Risk Factors; Trimetazidine; Vasodilator Agents | 1999 |
4 other study(ies) available for trimetazidine and Diabetic Angiopathies
| Article | Year |
|---|---|
Effectiveness and safety of anti-ischemic trimetazidine in patients with stable angina pectoris and Type 2 diabetes.
Topics: Aged; Angina, Stable; Canada; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Administration Schedule; Female; Humans; Male; Myocardial Ischemia; Prospective Studies; Pulse Wave Analysis; Trimetazidine; Vasodilator Agents | 2017 |
[A prospective study on trimetazidine effectiveness and tolerability in diabetic patients in association to the previous treatment of their coronary disease. DIETRIC study].
Topics: Adult; Aged; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Male; Middle Aged; Prospective Studies; Trimetazidine; Vasodilator Agents | 2005 |
Metabolic agents in the management of diabetic coronary patients: a new era.
Topics: Carnitine; Coronary Disease; Diabetes Mellitus; Diabetic Angiopathies; Dichloroacetic Acid; Enzyme Inhibitors; Epoxy Compounds; Humans; Perhexiline; Trimetazidine; Vasodilator Agents; Vitamin B Complex | 2008 |
Metabolic agents in the management of diabetic coronary patients: a new era.
Topics: Acetanilides; Citric Acid Cycle; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dichloroacetic Acid; Enzyme Inhibitors; Epoxy Compounds; Humans; Insulin Resistance; Perhexiline; Piperazines; Ranolazine; Trimetazidine; Vasodilator Agents | 2008 |